Comparison of percutaneous management techniques for recurrent malignant ascites.

The Pleurx subcutaneous tunneled catheter is approved for repeated, long-term drainage of malignant pleural effusions; however, there is limited literature describing its use in malignant ascites. The authors compared the safety and efficacy of two percutaneous drainage methods: large volume paracentesis and Pleurx catheter placement over a 41-month period. The Pleurx catheter provided effective palliation with a complication rate similar to that for large volume paracentesis, while preventing the need for frequent trips to the hospital for repeated percutaneous drainage.

[1]  R. Enck Palliative radiation therapy in hospice care , 2002, The American journal of hospice & palliative care.

[2]  P. Simone,et al.  Palliative Treatment of Malignant Refractory Ascites by Positioning of Denver Peritoneovenous Shunt , 2002, Tumori.

[3]  Robert E Enck Malignant ascites. , 2002, The American journal of hospice & palliative care.

[4]  T. Herzog,et al.  Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter , 2002, The American journal of hospice & palliative care.

[5]  K. Kihara,et al.  Intracavitary administration of OK‐432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinoma , 2002, International journal of urology : official journal of the Japanese Urological Association.

[6]  H. Richard,et al.  Pleurx tunneled catheter in the management of malignant ascites. , 2001, Journal of vascular and interventional radiology : JVIR.

[7]  J. Pector,et al.  Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998. , 2000, Hepato-gastroenterology.

[8]  J. Mackey,et al.  A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites. , 2000, Journal of pain and symptom management.

[9]  R. Malone,et al.  Octreotide as an agent for the relief of malignant ascites in palliative care patients , 1999, Palliative medicine.

[10]  W. Faught,et al.  A survey of practice in management of malignant ascites. , 1998, Journal of pain and symptom management.

[11]  J. Smyth,et al.  Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  T. Saclarides,et al.  Peritoneovenous shunts for palliation of the patient with malignant ascites , 1994, Annals of Surgical Oncology.

[13]  J. Krige,et al.  A new approach to the management of malignant ascites; a permanently implanted abdominal drain. , 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.